Related Experiment Video
Updated: Apr 26, 2026

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Why did Swiss citizens refuse a comprehensive second-hand smoke ban?
André-Dante Durham1, Pascal Diethelm2, Jacques Cornuz3
1Department of Ambulatory Care and Community Medicine, Lausanne University Hospital, Lausanne, Switzerland; andre.durham@chuv.ch.
Comprehensive smoking bans are crucial for public health, yet Switzerland
Area of Science:
- Public Health
- Tobacco Control Policy
Background:
- Second-hand smoke poses significant health risks.
- The World Health Organization Framework Convention on Tobacco Control advocates for comprehensive smoking bans.
- Switzerland implemented a partial smoking ban in 2010, mirroring the Spanish model.
Purpose of the Study:
- To analyze the reasons behind the Swiss citizens' rejection of a more comprehensive smoking ban in 2012.
- To derive lessons from this case study for future tobacco control strategies.
Main Methods:
- Case study analysis.
- Examination of the factors influencing public opinion and policy decisions in Switzerland regarding smoking bans.
Main Results:
- The study investigates the specific reasons for the public's refusal of a stricter smoking ban.
- Identifies key factors contributing to the policy's rejection.
Conclusions:
- The Swiss case highlights challenges in implementing comprehensive tobacco control measures.
- Lessons learned can inform public health policy and advocacy efforts globally.
More Related Videos
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease II: Emphysema
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Stress Prevention and Stress Management Techniques IV
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
PPE Use in Healthcare Settings II: Doffing